- Home
- CYTK vs CHRD Comparison
CYTK vs CHRD Comparison
Compare CYTK & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- CHRD
- Stock Information
- Founded
- CYTK 1997
- CHRD 2007
- Country
- CYTK United States
- CHRD United States
- Employees
- CYTK N/A
- CHRD N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- CHRD Oil & Gas Production
- Sector
- CYTK Health Care
- CHRD Energy
- Exchange
- CYTK Nasdaq
- CHRD Nasdaq
- Market Cap
- CYTK 4.6B
- CHRD 5.1B
- IPO Year
- CYTK 2004
- CHRD 2010
- Fundamental
- Price
- CYTK $58.45
- CHRD $89.71
- Analyst Decision
- CYTK Buy
- CHRD Strong Buy
- Analyst Count
- CYTK 16
- CHRD 12
- Target Price
- CYTK $76.73
- CHRD $137.42
- AVG Volume (30 Days)
- CYTK 2.0M
- CHRD 763.1K
- Earning Date
- CYTK 11-05-2025
- CHRD 11-04-2025
- Dividend Yield
- CYTK N/A
- CHRD 6.01%
- EPS Growth
- CYTK N/A
- CHRD N/A
- EPS
- CYTK N/A
- CHRD 4.47
- Revenue
- CYTK $85,738,000.00
- CHRD $4,967,177,000.00
- Revenue This Year
- CYTK $363.61
- CHRD N/A
- Revenue Next Year
- CYTK $64.08
- CHRD N/A
- P/E Ratio
- CYTK N/A
- CHRD $20.08
- Revenue Growth
- CYTK 2635.74
- CHRD 19.70
- 52 Week Low
- CYTK $29.31
- CHRD $79.83
- 52 Week High
- CYTK $63.86
- CHRD $136.38
- Technical
- Relative Strength Index (RSI)
- CYTK 60.20
- CHRD 32.17
- Support Level
- CYTK $58.84
- CHRD $90.43
- Resistance Level
- CYTK $63.86
- CHRD $92.34
- Average True Range (ATR)
- CYTK 2.52
- CHRD 2.65
- MACD
- CYTK -0.26
- CHRD -0.91
- Stochastic Oscillator
- CYTK 47.43
- CHRD 15.70
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.